Zobrazeno 1 - 2
of 2
pro vyhledávání: '"D. L. Vasquez"'
Autor:
C. A. Gonzalez Gomez, M. Cosatti, V. V. Castro Coello, M. Haye, Y. Tissera, A. A. Reyes, J. A. Albiero, S. Ornella, P. Alba, C. Gobbi, M. J. Gamba, I. E. Exeni, A. Cusa, J. Gallino Yanzi, V. I. Bellomio, G. Gomez, D. Zelaya, L. Takashima, L. Carlevaris, M. D. L. A. Correa, R. Rojas Tessel, M. García, N. German, A. L. Mercé, A. Bertoli, S. E. Aguero, M. E. Calvo, V. Martire, M. Mauri, M. L. Martin, E. Picco, D. Castrillon Bustamante, L. Ibañez Zurlo, M. N. Tamborenea, G. C. Subils, D. L. Vasquez, S. Soares de Souza, N. Herscovich, L. Raiti, V. Cosentino, F. Rodriguez, C. Ledesma, M. P. Diaz, M. L. Mamani Ortega, M. S. Castaño, G. Gómez, K. Roberts, R. Quintana, C. A. Isnardi, G. Pons-Estel, C. Pisoni
Publikováno v:
Annals of the Rheumatic Diseases. 81:1668-1669
BackgroundPersistent symptoms after acute COVID have been described previously. Main symptoms reported are fatigue, arthralgias, myalgias and mental sickness. Definition and methods vary widely.1ObjectivesTo asses prevalence and related factors to lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::101aa1b4b594901daa618a2c94872b64
https://doi.org/10.1136/annrheumdis-2022-eular.1021
https://doi.org/10.1136/annrheumdis-2022-eular.1021
Autor:
A. B. Gómez Vara, T. Barbich, C. A. Isnardi, E. E. Schneeberger, G. Citera, V. V. Castro Coello, R. Baez, M. Haye, A. A. Reyes, J. A. Albiero, R. Tanten, E. Velozo, P. Alba, M. J. Gamba, C. G. Alonso, H. Maldonado Ficco, J. Gallino Yanzi, V. Savio, C. Asnal, C. Matellan, L. Takashima, L. Carlevaris, M. S. Gálvez Elkin, J. Scafati, M. García, N. German, M. L. Werner, C. Aeschlimann, S. E. Aguero, M. E. Calvo, L. Gonzalez Lucero, G. F. Rodriguez Gil, M. Mauri, S. Petruzzelli, D. Castrillon Bustamante, L. Ibañez Zurlo, D. Alonso, J. L. Tomas, D. L. Vasquez, S. Soares de Souza, N. Herscovich, L. Raiti, J. M. Mareco, D. Guaglianone, C. Ledesma, M. P. Diaz, M. E. Bedoya, B. Kisluk, G. Gómez, K. Roberts, R. Quintana, G. Pons-Estel
Publikováno v:
Annals of the Rheumatic Diseases. 81:953.1-953
BackgroundHigh disease activity, treatment with glucocorticoids (GC) and rituximab (RTX), have been related to worse outcomes of COVID-19.ObjectivesTo assess the clinical characteristics and severity of the SARS-CoV-2 infection in patients with rheum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be049046514246c9739f081a9a610486
https://doi.org/10.1136/annrheumdis-2022-eular.3000
https://doi.org/10.1136/annrheumdis-2022-eular.3000